ROLE OF RENIN SECRETION AND KIDNEY-FUNCTION IN HYPERTENSION AND ATTENDANT HEART-ATTACK AND STROKE

被引:10
作者
LARAGH, JH
机构
[1] The New York Hospital-Cornell University Medical College, New York
关键词
D O I
10.3109/10641969209036189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Control of blood pressure usually has not, by itself, affected the incidence of heart attack in hypertensive patients. This suggests a need for cause-specific therapy targeted against mechanisms that engage the risks of myocardial infarction. Study of the renin system, the ongoing, long-term servo-control over blood pressure and electrolyte homeostasis may provide answers. Inappropriately high renin production, generating the powerful vasoconstrictor, angiotensin II, may cause ischemic vascular damage in the heart, kidney and brain, predisposing to infarction. Many clinical situations associated with high plasma renin levels are accompanied by striking vascular damage, heart attack, or stroke. A recent prospective study of 1,717 hypertensive patients shows an unequivocally positive relationship between myocardial infarction and high-renin status regardless of other risk factors such as smoking, hypercholesteremia, or diabetes. The data also suggest the possibility that renin is a continuous variable, since the risk of heart attack was significantly weaker in medium-renin than in high and significantly greater than in low renin subjects. These observations are in keeping with concept that any renin secretion in the face of arterial hypertension is abnormal, since the truly normal kidney completely turns off its renin secretion. Thus the renin-sodium profile appears to be especially useful for evaluating the large fraction of patients who develop heart attacks in the absence of these other risk factors. Altogether, these findings suggest that a renin test should be performed routinely in hypertensive patients, the better to assess prognosis and design appropriate anti-renin therapy.
引用
收藏
页码:285 / 305
页数:21
相关论文
共 38 条
  • [1] ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION
    ALDERMAN, MH
    MADHAVAN, S
    OOI, WL
    COHEN, H
    SEALEY, JE
    LARAGH, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) : 1098 - 1104
  • [2] PROLONGED INFUSIONS OF ANGIOTENSIN 2 AND NOREPINEPHRINE AND BLOOD PRESSURE ELECTROLYTE BALANCE AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES
    AMES, RP
    BORKOWSKI, AJ
    SICINSKI, AM
    LARAGH, JH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1965, 44 (07) : 1171 - +
  • [3] BERGLUND G, 1978, LANCET, V1, P1
  • [4] RENIN AS A RISK FACTOR IN ESSENTIAL HYPERTENSION - MORE EVIDENCE
    BRUNNER, HR
    SEALEY, JE
    LARAGH, JH
    [J]. AMERICAN JOURNAL OF MEDICINE, 1973, 55 (03) : 295 - 302
  • [5] ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE
    BRUNNER, HR
    BUHLER, FR
    BARD, RH
    BAER, L
    GOODWIN, FT
    NEWTON, MA
    KRAKOFF, LR
    LARAGH, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) : 441 - +
  • [6] BRUNNER HR, 1974, CIRC RES, V34, pI35
  • [7] PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES
    BUHLER, FR
    BRUNNER, HR
    BAER, L
    VAUGHAN, ED
    LARAGH, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) : 1209 - +
  • [8] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS
    CASE, DB
    ATLAS, SA
    LARAGH, JH
    SEALEY, JE
    SULLIVAN, PA
    MCKINSTRY, DN
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) : 195 - 206
  • [9] POSSIBLE ROLE OF RENIN IN HYPERTENSION AS SUGGESTED BY RENIN-SODIUM PROFILING AND INHIBITION OF CONVERTING ENZYME
    CASE, DB
    WALLACE, JM
    KEIM, HJ
    WEBER, MA
    SEALEY, JE
    LARAGH, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (12) : 641 - 646
  • [10] ESTIMATING RENIN PARTICIPATION IN HYPERTENSION - SUPERIORITY OF CONVERTING ENZYME-INHIBITOR OVER SARALASIN
    CASE, DB
    WALLACE, JM
    KEIM, HJ
    WEBER, MA
    DRAYER, JIM
    WHITE, RP
    SEALEY, JE
    LARAGH, JH
    [J]. AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) : 790 - 796